AI assistant
Sending…
NOVAVAX INC — Director's Dealing 2021
Mar 23, 2021
31982_dirs_2021-03-23_67be6282-9d6c-410d-9484-422dc11ce454.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NOVAVAX INC (NVAX)
CIK: 0001000694
Period of Report: 2021-03-19
Reporting Person: MCMANUS MICHAEL A JR (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-03-19 | Common Stock | S | 1000 | $221.40 | Disposed | 8951 | Direct |
| 2021-03-19 | Common Stock | S | 3000 | $220.57 | Disposed | 5951 | Direct |
More from NOVAVAX INC
Regulatory Filings
2026
May 6
Interim / Quarterly Report
2026
May 6
Annual Report
2026
Apr 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Regulatory Filings
2026
Feb 26
Annual Report
2026
Feb 26
Director's Dealing
2026
Jan 26